Filing Details
- Accession Number:
- 0001484612-22-000007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-19 20:52:00
- Reporting Period:
- 2022-01-18
- Accepted Time:
- 2022-01-19 20:52:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1484612 | Outset Medical Inc. | OM | Electromedical & Electrotherapeutic Apparatus (3845) | 200514392 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1823381 | L. John Brottem | 3052 Orchard Drive San Jose CA 95134 | General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-01-18 | 3,000 | $9.48 | 15,547 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-01-18 | 3,000 | $35.61 | 12,547 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-01-18 | 7,002 | $9.48 | 19,549 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-01-18 | 7,002 | $35.61 | 12,547 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-01-18 | 7,002 | $0.00 | 7,002 | $9.48 |
| Common Stock | Performance Options (right to buy) | Disposition | 2022-01-18 | 3,000 | $0.00 | 3,000 | $9.48 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 52,226 | 2030-05-26 | No | 4 | M | Direct | |
| 7,265 | 2030-05-26 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021.
- The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $34.00-$34.99 - 536 shares; $35.00-$35.99 - 5,814 shares; $36.00-$36.99 - 3,652 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.
- This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event.
Billionaire Hedge Funds
